These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8345717)

  • 1. [Shock wave therapy of the rabbit VX2 bladder cancer--THP-ADM concentration in the tissue after combination therapy of THP-ADM and shock wave].
    Suzuki K; Orikasa S; Hoshi S; Kuwahara M; Yoshikawa K; Ohyama C; Satou M; Kawamura S
    Nihon Hinyokika Gakkai Zasshi; 1993 Jun; 84(6):1007-12. PubMed ID: 8345717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tissue concentration of intravesically instilled (2"R)-4'-o-tetrahydropyranyl-adriamycin or adriamycin in superficial bladder cancer].
    Saika T; Tsushima T; Nasu Y; Noda M; Akebi N; Kaku S; Takamatsu M; Ohmori H; Uno S; Johsen T
    Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1206-10. PubMed ID: 8355436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infiltration and tissue concentration of intravesically instilled (2"R)-4'-O-tetrahydropyranyladriamycin or adriamycin in rat bladder tumor induced by BBN].
    Masuda H; Hirai M; Ohtawara Y; Tajima A; Aso Y
    Nihon Hinyokika Gakkai Zasshi; 1990 Apr; 81(4):577-82. PubMed ID: 2374330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A randomized study of pirarubicin (THP) versus adriamycin (ADM) for intravesical instillation therapy against superficial bladder cancer].
    Kawamura J; Tochigi H; Obata K; Ueda K; Otaguro K; Kuriyama M; Shinoda M; Naruse K; Murase T; Hasegawa Y
    Hinyokika Kiyo; 1992 Mar; 38(3):379-85. PubMed ID: 1523998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shock wave and THP-adriamycin for treatment of rabbit's bladder cancer.
    Hoshi S; Orikasa S; Kuwahara M; Suzuki K; Shirai S; Yoshikawa K; Nose M
    Jpn J Cancer Res; 1992 Mar; 83(3):248-50. PubMed ID: 1582886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of retention time of intravesical instillation therapy with pirarubicin (THP)].
    Sugano O; Shoji N; Hatakeyama T; Kato H
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1169-74. PubMed ID: 8751805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Appropriate intravesical retention time of pirarubicin concentration based on its level in tumor tissue, anti-tumor effect and side effect in intravesical instillation therapy for bladder tumor].
    Kobayashi M; Sugaya Y; Yuzawa M; Ochi M; Morita T; Kobayashi Y; Tokue A; Hara Y
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1771-4. PubMed ID: 9757205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High energy underwater shock wave treatment on implanted urinary bladder cancer in rabbits.
    Hoshi S; Orikasa S; Kuwahara M; Suzuki K; Yoshikawa K; Saitoh S; Ohyama C; Satoh M; Kawamura S; Nose M
    J Urol; 1991 Aug; 146(2):439-43. PubMed ID: 1649927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship of intracellular concentration and duration of contamination of pirarubicin and adriamycin in human bladder cancer cell lines and human bladder normal mucosa cell line].
    Saika T; Tsushima T; Nasu Y; Akebi N; Ohmori H
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):905-9. PubMed ID: 8678540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of intravesical instillation of pirarubicin for preventing recurrence of non-muscle invasive bladder cancer].
    Li Q; Xu T; Wang XF
    Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):904-7. PubMed ID: 20193328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative investigation on use of (2''R)-4'-O-tetrahydropyranyl-adriamycin and adriamycin as intravesical chemotherapy for superficial bladder tumors.
    Akaza H; Niijima T; Hisamatsu T; Fujigaki M
    Urology; 1988 Aug; 32(2):141-5. PubMed ID: 3400139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Postoperative intravesical instillation of THP for superficial bladder tumor: clinical results of prophylactic effects on the recurrence. Fukushima THP Research Group].
    Aikawa K; Irisawa C; Muraki O; Yamaguchi O; Shiraiwa Y; Noguchi M; Koguchi M; Yokoyama J; Ito K; Kumakawa K
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):509-13. PubMed ID: 1558401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model.
    Munck JN; Riggi M; Rougier P; Chabot GG; Ramirez LH; Zhao Z; Bognel C; Ardouin P; Herait P; Gouyette A
    Cancer Res; 1993 Apr; 53(7):1550-4. PubMed ID: 8453622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravesical chemotherapy of (2''R)-4'-O-tetrahydropyranyladriamycin in bladder tumor].
    Masuda H; Hirose J; Suzuki K; Tajima A; Aso Y
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2411-4. PubMed ID: 3729494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ultrastructural consequence of shock wave exposure on VX2 cancer implanted to the urinary bladder].
    Saitoh T; Orikasa S; Hoshi S; Suzuki K; Ioritani N; Taguchi K; Shirai S; Inaba Y
    Nihon Hinyokika Gakkai Zasshi; 1994 Oct; 85(10):1558-62. PubMed ID: 7990305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postoperative prophylactic intravesical instillation of tetrahydropyranyl-adriamycin (THP) for superficial bladder cancer].
    Kanayama H; Yokota K; Kurokawa Y; Kagawa S; Yokozeki H; Inai T; Ogawa I; Akazawa S; Hashimoto H; Mizuta K
    Gan To Kagaku Ryoho; 1999 Apr; 26(5):651-5. PubMed ID: 10234296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravesical instillation of pirarubicin (THP) together with polyvinylpyrrolidone (PVP) in the prevention of postoperative recurrence of superficial bladder cancer].
    Yu ZX; Weng ZL; Chen W; Zhang FY; Zhou XS; Li CD
    Ai Zheng; 2003 Apr; 22(4):421-3. PubMed ID: 12704004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined treatment in patients with carcinoma in situ of the urinary bladder using intravesical pirarubicin, irradiation and hyperthermia].
    Takechi T; Kawamura M; Nakagawa H; Inatsuki S; Akiyama K; Yano M; Sumiyoshi Y; Mandai K; Moriwaki S; Kataoka M
    Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2724-7. PubMed ID: 2277223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The intravesical recurrence after 3-day consecutive intravesical instillation of pirarubicine hydrochloride (THP) following transurethral resection of bladder tumor (TURBT) for non-muscle-invasive bladder cancer].
    Tochigi T; Sakurada Y; Aoki H; Kawamura S; Itou S; Satou I; Tateno H
    Nihon Hinyokika Gakkai Zasshi; 2012 Jul; 103(4):610-6. PubMed ID: 23120995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination therapy of high energy under water shock waves and anticancer drugs for subcutaneous murine bladder cancer (MBT-2)].
    Suzuki K; Orikasa S; Hoshi S; Yoshikawa K; Saitoh S; Ohyama C; Satoh M; Kawamura S
    Nihon Hinyokika Gakkai Zasshi; 1994 Oct; 85(10):1464-73. PubMed ID: 7990295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.